The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Smith Darren Charlton since 2026.
This trader's CIK number is 2122447.
At the time of last reporting, Smith Darren Charlton was the Group Chief Financial Officer of Telix Pharmaceuticals Ltd. (stock ticker symbol TLX).
Also see all insider trading activities at Telix Pharmaceuticals Ltd.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | TLX | 0 | $0 | 0 | $0 | 1,111 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-03-29 | TLX | Option Ex | 1,111 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Smith Darren Charlton (Group Chief Financial Officer of Telix Pharmaceuticals Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.